Thrombospondin 1 in hypoxia-conditioned media blocks the growth of human microvascular endothelial cells and is increased in systemic sclerosis tissues

Fibrogenesis and Tissue Repair

Volumn 4, Issue 1, 2011, Pages

  Morgan Rowe, Luke ^a   Nikitorowicz, Joanna ^a   Shiwen, Xu ^a   Leask, Andrew ^a   Tsui, Janice ^a   Abraham, David ^a   Stratton, Richard ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN BINDING PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT THROMBOSPONDIN 1; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MICROVASCULAR ENDOTHELIAL CELL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SKIN BIOPSY; SYSTEMIC SCLEROSIS;

EID: 79959984675     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-4-13     Document Type: Article

References (34)

1. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007, 117:557-567. 10.1172/JCI31139, 1804347, 17332883.
2. Kahaleh MB, Sherer GK, LeRoy EC. Endothelial injury in scleroderma. J Exp Med 1979, 149:1326-1335. 10.1084/jem.149.6.1326, 2184886, 312896.
3. Carvalho D, Savage CO, Black CM, Pearson JD. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro: induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest 1996, 97:111-119. 10.1172/JCI118377, 507068, 8550821.
4. Sgonc R, Gruschwitz MS, Boeck G, Sepp N, Gruber J, Wick G. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 2000, 43:2550-2562. 10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H, 11083280.
5. Worda M, Sgonc R, Dietrich H, Niederegger H, Sundick RS, Gershwin ME, Wick G. In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorioallantoic membrane assay. Arthritis Rheum 2003, 48:2605-2614. 10.1002/art.11179, 13130480.
6. Ahmed SS, Tan FK, Arnett FC, Jin L, Geng YJ. Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies. Arthritis Rheum 2006, 54:2250-2262. 10.1002/art.21952, 16802364.
7. Stein CM, Tanner SB, Awad JA, Roberts LJ, Morrow JD. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 1996, 39:1146-1150. 10.1002/art.1780390711, 8670323.
8. Ogawa F, Shimizu K, Muroi E, Hara T, Hasegawa M, Takehara K, Sato S. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis. Rheumatology (Oxford) 2006, 45:815-818.
9. Dooley A, Gao B, Bradley N, Abraham DJ, Black CM, Jacobs M, Bruckdorfer KR. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. Rheumatology (Oxford) 2006, 45:676-684.
10. Nuttall A, Derrett-Smith E, Stratton R. Vascular disease in scleroderma. Advances in Vascular Medicine 2010, 315-334. Berlin: Springer, Abraham A, Handler C, Dashwood M, Coghlan JG.
11. Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, Michel BA, Gay RE, Müller-Ladner U, Matucci-Cerinic M, Plate KH, Gassmann M, Gay S. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 2004, 95:109-116. 10.1161/01.RES.0000134644.89917.96, 15178641.
12. Davies CA, Jeziorska M, Freemont AJ, Herrick AL. The differential expression of VEGF, VEGFR-2 and GLUT-1 proteins in disease subtypes of systemic sclerosis. Hum Pathol 2006, 37:190-197. 10.1016/j.humpath.2005.10.007, 16426919.
13. Hummers LK, Hall A, Wigley FM, Simons M. Abnormalities in the regulators of angiogenesis in patients with scleroderma. J Rheumatol 2009, 36:576-582. 10.3899/jrheum.080516, 19228661.
14. Hebbar M, Peyrat JP, Hornez L, Hatron PY, Hachulla E, Devulder B. Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum 2000, 43:889-893. 10.1002/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5, 10765935.
15. Macko RF, Gelber AC, Young BA, Lowitt MH, White B, Wigley FM, Goldblum SE. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma): relationship to platelet and endothelial cell activation. J Rheumatol 2002, 29:2565-2570.
16. Mulligan-Kehoe MJ, Drinane MC, Mollmark J, Casciola-Rosen L, Hummers LK, Hall A, Rosen A, Wigley FM, Simons M. Antiangiogenic plasma activity in patients with systemic sclerosis. Arthritis Rheum 2007, 56:3448-3458. 10.1002/art.22861, 17907150.
17. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ. THMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992, 99:683-690. 10.1111/1523-1747.ep12613748, 1361507.
18. Lawler JW, Slayter HS, Coligan JE. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 1978, 253:8609-8616.
19. Bornstein P. Thrombospondins: structure and regulation of expression. FASEB J 1992, 6:3290-3299.
20. Bentley AA, Adams JC. The evolution of thrombospondins and their ligand-binding activities. Mol Biol Evol 2010, 27:2187-2197. 10.1093/molbev/msq107, 20427418.
21. Mumby SM, Raugi GJ, Bornstein P. Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen. J Cell Biol 1984, 98:646-652. 10.1083/jcb.98.2.646, 2113082, 6693501.
22. Lahav J, Schwartz MA, Hynes RO. Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: interaction of thrombospondin with fibronectin and collagen. Cell 1982, 31:253-262. 10.1016/0092-8674(82)90425-1, 7159924.
23. Mosher DF, Doyle MJ, Jaffe EA. Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell Biol 1982, 93:343-348. 10.1083/jcb.93.2.343, 2112841, 7096442.
24. Wikner NE, Dixit VM, Frazier WA, Clark RA. Human keratinocytes synthesize and secrete the extracellular matrix protein, thrombospondin. J Invest Dermatol 1987, 88:207-211. 10.1111/1523-1747.ep12525350, 3543145.
25. Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 1992, 90:1513-1522. 10.1172/JCI116019, 443198, 1383273.
26. Agah A, Kyriakides TR, Lawler J, Bornstein P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 2002, 161:831-839. 10.1016/S0002-9440(10)64243-5, 1867266, 12213711.
27. Kopp HG, Hooper AT, Broekman MJ, Avecilla ST, Petit I, Luo M, Milde T, Ramos CA, Zhang F, Kopp T, Bornstein P, Jin DK, Marcus AJ, Rafii S. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. J Clin Invest 2006, 116:3277-3291. 10.1172/JCI29314, 1679710, 17143334.
28. Nör JE, Mitra RS, Sutorik MM, Mooney DJ, Castle VP, Polverini PJ. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J Vasc Res 2000, 37:209-218. 10.1159/000025733, 10859480.
29. Phelan MW, Forman LW, Perrine SP, Faller DV. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. J Lab Clin Med 1998, 132:519-529. 10.1016/S0022-2143(98)90131-7, 9851743.
30. Zhang X, Kazerounian S, Duquette M, Perruzzi C, Nagy JA, Dvorak HF, Parangi S, Lawler J. Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J 2009, 23:3368-3376. 10.1096/fj.09-131649, 2747678, 19528255.
31. Farina G, Lafyatis D, Lemaire R, Lafyatis R. A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 2010, 62:580-588. 3018285, 20112379.
32. Distler JH, Jüngel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci-Cerinic M, Schett G, Marti HH, Gay S, Distler O. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum 2007, 56:4203-4215. 10.1002/art.23074, 18050252.
33. Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-β signaling in cultured scleroderma fibroblasts. Am J Pathol 2005, 166:1451-1463. 10.1016/S0002-9440(10)62362-0, 1606399, 15855645.
34. Favier J, Germain S, Emmerich J, Corvol P, Gasc JM. Critical overexpression of thrombospondin 1 in chronic leg ischaemia. J Pathol 2005, 207:358-366. 10.1002/path.1833, 16110458.